title: Safety of abacavir therapy after temporary interruptions in patients without hypersensitivity reactions to the drug.
authors.forename: Juan
authors.initials: J
authors.lastname: Berenguer
authors.forename: Belén
authors.initials: B
authors.lastname: Padilla
authors.forename: Vicente
authors.initials: V
authors.lastname: Estrada
authors.forename: Carlos
authors.initials: C
authors.lastname: Martín
authors.forename: Pere
authors.initials: P
authors.lastname: Domingo
authors.forename: José María
authors.initials: JM
authors.lastname: Kindelán
authors.forename: José María
authors.initials: JM
authors.lastname: Ruiz-Giardin
authors.forename: José María
authors.initials: JM
authors.lastname: Ruiz-Guiardin
mesh_terms: D000328:Adult; D015224:Dideoxynucleosides / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000099227:Abacavir
chemical_list: D015224:Dideoxynucleosides; D000099227:Abacavir